234 related articles for article (PubMed ID: 20957628)
1. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G
Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
4. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
Mrena J; Wiksten JP; Nordling S; Kokkola A; Ristimäki A; Haglund C
J Clin Pathol; 2006 Jun; 59(6):618-23. PubMed ID: 16731602
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
6. The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
Czyzewska J; Guzińska-Ustymowicz K; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2008; 46(1):57-64. PubMed ID: 18296264
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Zhang Q; Wang P; Shao M; Chen SW; Xu ZF; Xu F; Yang ZY; Liu BY; Gu QL; Zhang WJ; Li Y
Tumori; 2015; 101(5):566-71. PubMed ID: 26350198
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
[TBL] [Abstract][Full Text] [Related]
10. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
11. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival].
Zhao ZS; Yao GY; Ru GQ; Ma J; Ruan J
Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):169-72. PubMed ID: 15842896
[TBL] [Abstract][Full Text] [Related]
13. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
Li L; Zhang S; Lin H; Lin JY
Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.
Ye XT; Guo AJ; Yin PF; Cao XD; Chang JC
Med Oncol; 2014 Jul; 31(7):61. PubMed ID: 24943992
[TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-12 is associated with overall survival in Chinese patients with gastric cancer.
Zheng J; Chu D; Wang D; Zhu Y; Zhang X; Ji G; Zhao H; Wu G; Du J; Zhao Q
J Surg Oncol; 2013 Jun; 107(7):746-51. PubMed ID: 23280473
[TBL] [Abstract][Full Text] [Related]
17. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Huang L; Xu AM; Peng Q
Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
[TBL] [Abstract][Full Text] [Related]
18. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
[TBL] [Abstract][Full Text] [Related]
19. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer.
He L; Chu D; Li X; Zheng J; Liu S; Li J; Zhao Q; Ji G
Dig Dis Sci; 2013 May; 58(5):1264-70. PubMed ID: 23314917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]